Skip to content

Tumour educated platelets in the (early) diagnosis of ovarian cancer.

Tumour educated platelets in the (early) diagnosis of ovarian cancer. - TEP's in ovarian cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON50501
Enrollment
200
Registered
2017-04-06
Start date
2017-04-18
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer of the ovary Ovarian cancer

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Surgery becasuse of ovarian mass and/or surgery becasue of suspician of ovarian cancer

Exclusion criteria

Exclusion criteria: Suffering from other malignancies than ovariancancer

Design outcomes

Primary

MeasureTime frame
The difference in blood platelet RNA profile between ovarium cancer and benign ovarium lesions.

Secondary

MeasureTime frame
none

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 22, 2026